Michael Berelowitz

Filings by Michael Berelowitz span 2 companies, the busiest being Societal CDMO, Inc. and Oramed Pharmaceuticals Inc. We count 17 filings; the first trade dates from 31 March 2014 and the latest from 18 May 2022.

The open-market record consists of 5 sales worth €152k, with no purchase. Outside the open market, there are 8 share grants and 4 option exercises.

Most recently, on 20 May 2022, the filings show a share grant in Societal CDMO, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.